IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.946
EU - Europa 3.123
AS - Asia 1.086
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 13
OC - Oceania 10
AF - Africa 2
Totale 20.195
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.930
SE - Svezia 981
CN - Cina 931
FR - Francia 678
IT - Italia 527
DE - Germania 225
GB - Regno Unito 218
FI - Finlandia 193
UA - Ucraina 141
BE - Belgio 61
VN - Vietnam 53
IE - Irlanda 43
IN - India 37
IR - Iran 22
EU - Europa 15
CA - Canada 12
SG - Singapore 10
AT - Austria 7
AU - Australia 7
NL - Olanda 6
TR - Turchia 6
BR - Brasile 5
HR - Croazia 5
ID - Indonesia 5
AR - Argentina 4
CZ - Repubblica Ceca 4
ES - Italia 4
CH - Svizzera 3
JP - Giappone 3
LU - Lussemburgo 3
RO - Romania 3
RU - Federazione Russa 3
TH - Thailandia 3
AM - Armenia 2
CL - Cile 2
EE - Estonia 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MP - Marianne Settentrionali, isole 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 20.195
Salva come PNG Salva come JPEG
Città #
Fairfield 2.590
Woodbridge 1.855
Houston 1.403
Chandler 1.386
Ashburn 1.164
Seattle 1.065
Cambridge 934
Ann Arbor 922
Wilmington 809
Nyköping 804
Jacksonville 445
Lawrence 328
Roxbury 313
Nanjing 260
Beijing 237
Des Moines 202
Bari 181
Princeton 177
Inglewood 174
New York 169
San Diego 114
Dearborn 80
Shenyang 73
Boardman 68
Brussels 61
Paris 61
Hebei 59
London 59
Dong Ket 52
Nanchang 52
Jiaxing 50
Dublin 43
Tianjin 38
Brooklyn 36
Changsha 35
Redwood City 31
Pune 24
Falls Church 19
Los Angeles 18
Jinan 15
Norwalk 15
San Mateo 15
Milan 14
San Francisco 14
Augusta 13
Guangzhou 13
Prescot 13
Ardabil 12
Hounslow 12
Washington 12
Zhengzhou 12
Chicago 11
Indiana 11
Durham 10
Hefei 10
Helsinki 10
Kilburn 10
Monmouth Junction 10
Giovinazzo 9
Leawood 9
Gallarate 8
Toronto 8
Islington 7
Singapore 7
Vienna 7
Acton 6
Brindisi 6
Edinburgh 6
Hangzhou 6
Kunming 6
Ningbo 6
Taizhou 6
Tappahannock 6
Taranto 6
Triggiano 6
Chiswick 5
Rome 5
Trani 5
Cerignola 4
Fuzhou 4
Mola Di Bari 4
New Bedfont 4
Pescara 4
Verona 4
Zagreb 4
Boston 3
Canberra 3
Detroit 3
Esslingen am Neckar 3
Frankfurt am Main 3
Grumo Appula 3
Konstanz 3
Luxembourg 3
Melbourne 3
Mumbai 3
Nanning 3
Naples 3
Oberursel 3
Ostwald 3
Shanghai 3
Totale 16.826
Salva come PNG Salva come JPEG
Nome #
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 136
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 135
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 127
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 121
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 121
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 117
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 115
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 115
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 114
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 114
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 113
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 112
Digital ulcers predict a worse disease course in patients with systemic sclerosis 111
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 109
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 107
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 107
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 106
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 106
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 106
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 105
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 104
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 103
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 103
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 103
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 103
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 102
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 102
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 101
null 101
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 101
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 101
Management of Small Vessel Vasculitides 100
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 98
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 98
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 98
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 98
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 98
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice 97
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 97
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 97
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 96
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 96
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 96
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 95
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 95
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 95
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 94
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 93
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 93
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 92
Serum amyloid-A in Behçet's disease 92
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 92
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 92
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 92
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis 91
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 91
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 91
null 90
Untangling the web of systemic autoinflammatory diseases 89
Obesity and Inflammation – Targets for OA Therapy 88
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 88
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 88
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 88
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 88
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 87
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 87
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 87
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 87
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 87
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 87
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 86
null 86
null 86
Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art 86
Sarcoidosis presenting with Raynaud's syndrome: a case report 85
null 85
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 85
PHENOTYPING OF CHONDROCYTES FROM HUMAN OSTEOARTHRITIC CARTILAGE: CHONDROCYTE EXPRESSION OF BETA INTEGRINS AND CORRELATION WITH ANATOMIC INJURY 84
null 84
null 84
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 84
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 84
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 83
null 83
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 83
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 83
Isolated thrombocytopenia associated with low dose methotrexate therapy 82
null 82
Prevalence of anti-CCP antibodies in systemic sclerosis 82
null 82
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 82
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology 81
null 81
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 81
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 81
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 81
Peripheral and central nervous system correlates in fibromyalgia 81
null 80
HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: A systematic review and meta-analysis 80
null 79
Totale 9.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.595 0 0 0 0 0 0 0 0 0 324 638 633
2019/20206.346 974 234 138 464 729 605 652 693 781 399 457 220
2020/20213.478 215 317 252 149 584 251 291 293 329 369 213 215
2021/20222.515 193 226 41 126 109 186 164 148 154 172 346 650
2022/20233.770 582 442 292 306 373 504 79 440 551 28 111 62
2023/20241.075 107 261 59 99 106 272 38 68 17 48 0 0
Totale 21.450